The Patent Finder

C5aR ANTAGONISTS

Chemocentryx, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 61/139,919, filed Dec 22, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,906,938C5aR ANTAGONISTS
In force
 · High confidence
Chemocentryx, Inc.In force
High confidence
US 9,126,939C5AR Antagonists
In force
 · High confidence
Chemocentryx, Inc.In force
High confidence
US 9,573,897C5AR Antagonists
In force
 · High confidence
Chemocentryx, Inc.In force
High confidence
US 10,035,768C5AR Antagonists
In force
 · High confidence
Chemocentryx, Inc.In force
High confidence
US 10,660,897C5aR ANTAGONISTS
In force
 · High confidence
Chemocentryx, Inc.In force
High confidence
US 8,445,515C5aR ANTAGONISTS
In force
 · High confidence
Chemocentryx, Inc.In force
High confidence
Application 12/823,039C5aR ANTAGONISTS
Abandoned
Abandoned Dec 19, 2012
Chemocentryx, Inc.AbandonedAbandoned Dec 19, 2012
Application 13/072,616C5aR ANTAGONISTS
Abandoned
Abandoned Jan 27, 2015
Chemocentryx, Inc.AbandonedAbandoned Jan 27, 2015
Application 14/531,385C5aR ANTAGONISTS
Abandoned
Abandoned Jan 22, 2017
Chemocentryx, Inc.AbandonedAbandoned Jan 22, 2017
Application 15/354,878C5aR ANTAGONISTS
Abandoned
Abandoned Aug 7, 2018
Chemocentryx, Inc.AbandonedAbandoned Aug 7, 2018
7 more patents in this group · Pro
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17.
Upgrade to Pro
6 of these are in force and held by Chemocentryx, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited